|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 13, 2013 ) Boca Raton, FL --- This segment will focus on the challenges of developing innovative medical device and drug therapies for global markets and how a leading global contract research organization like Toxikon can help navigate developmental and regulatory hurdles.
Toxikon is a preclinical contract research organization (CRO) that partners with the biotech, pharmaceutical and medical device industries to deliver exceptional product development services from concept to final product.
From combination products to anticancer or antiviral compounds, Toxikon‘s team of distinguished scientists offers a broad portfolio of services for the development of medical devices and therapies that ultimately improve the quality of life. Well versed in a comprehensive range of compound structures and therapeutic targets, they provide the technical, research, and development expertise to meet clients’ development goals and time to market.
JL Haber, Vice President of Programming at Multi Media Productions, adds, “Toxikon is an innovator and a leader in their industry. We are excited to have them as a guest on our program.”
About Toxikon
Founded in 1982, Toxikon has enabled innovation in the pharmaceutical, biotechnology and medical device industries for more than 20 years. The company’s safety services include toxicology, pharmacokinetics, ADME, chemical characterization, bioanalytical, and microbiology/virology services. Toxikon’s certifications and licenses allow it to meet extensive regulatory requirements for international data acceptability.
“At Toxikon, we are committed to quality,” says Dr. Laxman Desai, President and CEO of Toxikon. “Our onsite team of registered quality assurance and regulatory professionals not only audit our own quality management systems, protocols, and suppliers but also guide our customers through the complex regulatory process,” he explains.
Toxikon has 250 full-time employees in two primary locations: a 117,000 square foot state-of-the art facility in Bedford, Massachusetts and a 20,000 square foot European lab operation in Leuven, Belgium.
Toxikon’s laboratory facilities are fully ISO/IEC 17025 accredited including GLP/GMP registrations, and the Bedford facilities have full USDA, OLAW, and AAALAC animal testing credentials. In addition to the laboratory facilities, the company has extensive and fully equipped surgical suites, along with support services that include efficacy and research services, and histology and clinical pathology. The company has remote technical sites in India, Japan, Minneapolis (USA), Israel, Germany, and Korea.
For more information go to http://www.toxikon.com/
About 21st Century Health
21st Century Health is an award winning targeted health show that is independently produced by Multi-Media Productions. The show provides its health viewers an in-depth opportunity to find solutions to the industry problems from some of the top health leaders from across the world. Each exclusive segment is taped in our state-of-the art South Florida Studio.
Once selected, companies are able to present their story and solutions to industry problems in an exclusive way that sets their company apart from the others. With more than 6,000 companies participating on over 600 shows, 21st Century Health continues to be the premier and targeted outlet for the latest health stories.
21st Century Health airs on various national cable networks that are viewed by over 100 million viewers nationwide as well as internationally via DirecTV and Dish Network. The 21CHTV Series is also available at more than 27 prestigious college universities, including Carnegie Mellon University, Howard University, Dartmouth College and Georgetown University.
For specific market-by-market air dates and times, please e-mail Moniqueh@mmpusa.com. For more information, please visit http://www.21chtv.com.
MultiMedia Productions
Gila Stern
561-988-9449 ext 269
gstern@mmpusa.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
